Although further investigation is indicated to better understand the impact of this technique on the control of diabetes, this work provides mechanistic insights into the antiinflammatory and therapeutic effects of biased, engineered IL-2 molecules and a conceptual basis for their use as therapeutic agents in select autoimmune and inflammatory diseases. Here, IL2 is linked to diabetes mellitus.